Merck withdraws arthritis drug worldwide
- 7 October 2004
- Vol. 329 (7470), 816.2-816
- https://doi.org/10.1136/bmj.329.7470.816-a
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Risk of Cardiovascular Events Associated With Selective COX-2 InhibitorsJAMA, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000